Johannesson, Emilia
Erixon, Clara
Sterner, Niklas
Thelaus, Louise
Dardashti, Alain
Nilsson, Johan http://orcid.org/0000-0001-6860-6090
Ragnarsson, Sigurdur
Linder, Adam
Zindovic, Igor
Article History
Received: 18 January 2023
Accepted: 27 November 2023
First Online: 7 December 2023
Competing interests
: Dr. Linder is listed as one of the inventors of a pending patent for HBP as a biomarker in sepsis filed by Hansa Medical. The patent applicant is Hansa Biopharma, a medical company with no attachments to Dr. Linder. The inventor is Heiko Herwald, Per Ã…kesson, Bertil Christensson, Protiga AB and Adam Linder. The application number is EP 2129391 B1. The application is granted for measuring quantities of HBP correlating with susceptibility to severe sepsis. No specific aspect relating to the patent is covered in the manuscript other than the fact it is the same measured biomarker but for a different indication not covered by the patent. The remaining authors have no competing interests to declare.